Research Directory

MedNous Briefing - The European Medicine Agency's PRIME Scheme

Read more

The story behind the discovery of Keytruda

Read more

Biotechs post higher values in 2016 fourth quarter

Read more

Market Commentary: How risky are European biotechs?

Read more

The stately progress of antibiotics

Read more

Market Analysis: The outlook for European pharma

Read more

New risk capital for European companies

Read more

Debate heats up over germline editing

Read more

Q3 stock market performance

Read more

Bioelectronics creates new horizon for medicine

Read more